Fermentas International

Molecular biology products
Invested in
2007
Status

Acquired by Thermo Fisher Scientific 2010

Location
Burlington, Canada
Sector
Healthcare & Life Sciences
Sector
Healthcare & Life Sciences
Website

"Summit helped us expand in Europe and penetrate North America and Asia – from making acquisitions, to recruiting, to raising our profile in the diagnostics industry – laying the foundation for a successful sale."

Dr. Viktorus Butkus
Former CEO
|
Fermentas International
2x

EBIDTA growth in three years

$260M

Acquired by Thermo Fisher Scientific in 2010

2x

EBIDTA growth in three years

$260M

Acquired by Thermo Fisher Scientific in 2010

With origins dating back to the 1970s, Fermentas produced molecular biology products for scientific research. Fermentas grew to be the dominant player in Europe, and sought an experienced life sciences partner to solidify this leading position while helping expand geographically into North America and Asia.

How Summit Partners Helped

  • Led a minority investment in 2007, helping to fund a state-of-the-art clean room manufacturing facility
  • Recruited Ken Fong, Ph.D., founder of Summit portfolio company Clontech Laboratories, as advisor
  • Helped strengthen the company’s infrastructure by building financial controls and improving reporting standards
  • Assisted in the establishment of new sales offices in China and North America and helped acquire several distributors
  • Provided strategic guidance focused on driving investments in new product development and sales force expansion through critical analysis
  • Helped evaluate strategic interest from potential acquirers and select the eventual acquirer

Fermentas had become one of the largest privately held companies in the molecular biology industry, selling more than 1000 products to leading researchers around the world. In 2010, Fermentas was acquired by Thermo Fisher Scientific.

The Portfolio Company Executive quoted herein did not receive compensation for any statements regarding Summit Partners. However, since Fermentas International is a former portfolio company of Summit, this individual did receive general compensation in connection with his employment by the company. In addition, this individual is not an investor in a Summit fund but may have conflicts arising from his past role with Fermentas International due to the company’s relationship with Summit.

Related News

No items found.
No items found.
Button Text

Get the Latest from Summit Partners

Subscribe to our newsletter to stay up to date on our partners, portfolio, and more.